Also trades as: PETVW (NASDAQ) · $vol 0M
PETV OTC
PetVivo Holdings, Inc.
1W: -10.6%
1M: +10.9%
3M: -6.2%
YTD: -34.8%
1Y: -37.0%
3Y: -57.6%
5Y: -76.0%
$0.75
-0.05 (-6.25%)
Weekly Expected Move ±11.1%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider+$0.2M
Congress—
ETF Holdings—
Key Statistics
Market Cap$28.2M
52W Range0.5899-1.69
Volume5,100
Avg Volume10,576
Beta1.24
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJohn Lai
Employees22
SectorHealthcare
IndustryMedical - Devices
IPO Date2014-09-08
Websitepetvivo.com
5251 Edina Industrial Boulevard
Edina, MN 55439
US
Edina, MN 55439
US
952 405 6216
About PetVivo Holdings, Inc.
PetVivo Holdings, Inc. operates as a biomedical technology firm, specializing in the invention, commercialization, and licensing of advanced medical devices and biomaterials intended to treat a variety of ailments and diseases affecting animals. Its flagship product is Spryng, an intra-articular injection administered by veterinarians to effectively alleviate lameness and joint conditions, such as osteoarthritis, in canines and equines. The company's development pipeline further includes seventeen therapeutic devices poised for both veterinary and human clinical applications. Founded in 2009, PetVivo Holdings, Inc. maintains its corporate headquarters in Minneapolis, Minnesota.
Latest News
PetVivo Holdings, Inc. to Present at the Life Sciences Investor Forum on June 24th
PetVivo Issues Correction and Replacement Press Release; Sets Fiscal Third Quarter 2026 Conference Call for Tuesday, February 17, 2026 at 5:00 p.m. ET
PetVivo Sets Fiscal Third Quarter 2026 Conference Call for Monday, February 16, 2026 at 5:00 p.m. ET
PetVivo Holdings, Inc. Presenting at the 3rd Annual DealFlow Discovery Conference
PetVivo.ai Breaks the Mold: Launches Video Explainer Because "Nobody Reads Tech Press Releases Anymore"
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Rudelius Robert Jame | A-Award | 2,000 | $0.72 | 2026-09-18 |
| Rudelius Robert Jame | A-Award | 1,497 | $0.75 | 2026-09-18 |
| A.L. Sarroff Fund, L | P-Purchase | 24,888 | $0.69 | 2026-09-14 |
| A.L. Sarroff Fund, L | P-Purchase | 10,974 | $0.68 | 2026-09-10 |
| A.L. Sarroff Fund, L | P-Purchase | 22,160 | $0.68 | 2026-09-09 |